Clinical Trials Logo

Households clinical trials

View clinical trials related to Households.

Filter by:
  • None
  • Page 1

NCT ID: NCT05467917 Recruiting - COVID-19 Clinical Trials

ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases

Start date: August 1, 2021
Phase:
Study type: Observational

The goal of this project is to understand the household level transmission dynamics and factors that predict transmission of SARS-COV-2 between pediatric and adults in the household. The novel coronavirus SARS-CoV-2 has spread all around the world and testing has posed a challenge globally. Not much is known about who does and does not acquire SARS-CoV2. It is also unknown who will show symptoms or progress severe disease or death from COVID-19. Children tend to have milder symptoms or none at all. Therefore, few children have ever been tested, so it is unknown if they get the infection as much as anyone else. Health care providers are highly exposed, and they do not get tested unless they show severe symptoms. If groups like children and health workers are infected, they can unknowingly spread SARS-CoV-2, unless they practice behaviors like self-isolation very strictly. The investigators aim to measure the prevalence of SARS-CoV-2 in children and health care workers at a large urban health center. The investigators will also measure how many people in the household of the positive children and health care workers also get SARS-CoV-2 infection. Lastly, the investigators will see what other risk factors affect who acquires SARSCoV-2 from inside or outside of the household clusters.

NCT ID: NCT04973371 Completed - Clinical trials for Tuberculosis, Pulmonary

Acceptability and Feasibility of Home-based TB Testing

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate the utility of home-based point-of-care TB testing for early diagnosis and linkage to care of household contacts of TB patients, addressing the need for active case finding and early detection of infectious TB. The investigators propose an exploratory study to 1) investigate the acceptability and feasibility of home-based TB testing of household contacts using a new portable GeneXpert point-of-care (PoC) platform, and 2) determine the potential impact of such a home-based testing program on early detection of TB disease and linkage-to-care (LTC).

NCT ID: NCT04485377 Completed - Households Clinical Trials

Safety Net Support Use in California

ACCESS
Start date: August 1, 2020
Phase:
Study type: Observational

The investigator's goal is to promote equity by understanding the drivers of disparities in access to income support, particularly among urban and rural Latinx, African American, and white populations in California (CA). This study aims to capture levels of awareness, barriers to uptake, and the benefits of participation in the Earned Income Tax Credit (EITC), a tax credit for low- to moderate-income working individuals and families, among households with children ages 0-5 years old. To achieve this goal, the investigators will conduct a mixed-methods, cross-sectional, descriptive study in three diverse counties in California: Los Angeles (urban, nearly half Latinx), Alameda (urban, ethnically diverse), and Merced (rural, predominantly Latinx and white).

NCT ID: NCT04205669 Completed - Scabies Clinical Trials

Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon

Start date: October 4, 2018
Phase: Phase 4
Study type: Interventional

It is unclear whether individual treatment of scabies is similarly effective compared to household treatment. This study therefore compares these two treatment strategies with topical benzyl benzoate for treating scabies in Lambaréné and surroundings in Gabon. Subjects presenting with uncomplicated scabies are randomized into either the Individual Treatment group, where only the affected subjects receive treatment, or the Household Treatment group, where all family members are treated in parallel to the affected subjects regardless of signs and symptoms. The primary endpoint is clinical cure after 28 days; the secondary endpoint is the proportion of affected household members per household after 28 days.

NCT ID: NCT03799185 Completed - Atherosclerosis Clinical Trials

Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population

ATERASurvey
Start date: January 4, 2016
Phase:
Study type: Observational [Patient Registry]

ATERA Survey is a national cross sectional observational study, aiming to determine the prevalence of dyslipidemia and other conventional risk factors for CHD (Coronary Heart Disease), the relationship between environmental and lifestyle factors with dyslipidemia, the perception and the knowledge of cardiovascular risk factors by the population, and above all, to strengthen the national strategy for primary and secondary prevention against coronary heart disease.